​

Funding Round

Post-IPO Equity - Moderna

Post-IPO Equity - Moderna

Investment Firm

Overview

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Announced Date

Oct 12, 2022

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

MSD Capital

MSD Capital

MSD Capital is a early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorMSD Capital

Round Details and Background

Moderna raised $250000000 on 2022-10-12 in Post-IPO Equity

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Company Funding History

15

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 14, 2014
Corporate Round - Moderna
1-25.0M
Nov 20, 2013
Venture Round - Moderna
1-110.0M
Oct 02, 2013
Grant - Moderna
1-24.6M
Dec 06, 2012
Venture Round - Moderna
1-40.0M

Recent Activity

There is no recent news or activity for this profile.